Hana Biosciences Inc (NASDAQ:HNAB) to Hold Q4 2007 Earnings Conference Call March 25

Hana Biosciences Inc (NASDAQ:HNAB) will hold a conference call on Tuesday, March 25 at 5:00 pm to discuss the fourth quarter earnings for 2007.

A California based biopharmaceutical company, Hana Biosciences is focused on the acquisition, development and commercialization of products to advance cancer care.  Hana is currently seeking to license late preclinical and early clinical oncology product candidates from academia and research institutes to accelerate clinical development and time to commercialization.

No revenue has been generated yet, as of December 31, 2006 due to the company’s lack of approval for the sale of its drug candidates.  The company’s pipeline of oncology focused candidates include therapeutic product candidates to for the destruction of cancer cells and supportive care product candidates to treat or prevent therapeutic cancer treatment side effects.

Hana is in the development stages for six product candidates, four are therapeutic and two are support care product candidates.

Hana Biosciences Inc (NASDAQ:HNAB)

To view more Conference Call related events or to post your own events, visit:

http://events.finditt.com/Events_List.aspx?catid=12